Pfizer
PFE
$26.00
Share price
2.40%
Change (1 day)
-35.39%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Net assets
Net assets on the balance sheet as of December 2023 : $89.28 B
According to Pfizer's latest financial reports the company has $89.28 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Pfizer - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $89.28 B | -6.91% |
| 2022-12-31 | $95.91 B | 23.82% |
| 2021-12-31 | $77.46 B | 22.04% |
| 2020-12-31 | $63.47 B | 0.04% |
| 2019-12-31 | $63.44 B | -0.49% |
| 2018-12-31 | $63.75 B | -11.02% |
| 2017-12-31 | $71.65 B | 19.75% |
| 2016-12-31 | $59.84 B | -7.94% |
| 2015-12-31 | $64.99 B | -9.25% |
| 2014-12-31 | $71.62 B | -6.52% |
| 2013-12-31 | $76.62 B | -6.19% |
| 2012-12-31 | $81.67 B | -1.14% |
| 2011-12-31 | $82.62 B | -6.39% |
| 2010-12-31 | $88.26 B | -2.41% |
| 2009-12-31 | $90.44 B | 56.64% |
| 2008-12-31 | $57.74 B | -11.34% |
| 2007-12-31 | $65.12 B | -8.83% |
| 2006-12-31 | $71.43 B | 8.62% |
| 2005-12-31 | $65.76 B | -3.68% |
| 2004-12-31 | $68.27 B | 4.44% |
| 2003-12-31 | $65.37 B | 227.7% |
| 2002-12-31 | $19.95 B | 9.06% |
| 2001-12-31 | $18.29 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -22.98% | 🇺🇸 USA |
 Novartis NVS | $46.75 B | -47.64% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $38.82 B | -56.51% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | -87.83% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | -93.02% | 🇺🇸 USA |
 Merck MRK | $37.63 B | -57.85% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | -66.98% | 🇺🇸 USA |
 AstraZeneca AZN | $39.16 B | -56.14% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.28 B | -81.76% | 🇬🇧 UK |